PA Blueprint Review: Hematologic, Infectious Disease, and Musculoskeletal Systems - A Clinical Reference and Board Review for the PANCE and PANRE (PA ... Recertification Review Book 4 Volume Series) by PA Blueprint Review

PA Blueprint Review: Hematologic, Infectious Disease, and Musculoskeletal Systems - A Clinical Reference and Board Review for the PANCE and PANRE (PA ... Recertification Review Book 4 Volume Series) by PA Blueprint Review

$32.99
Sale price  $32.99 Regular price 
Skip to product information
PA Blueprint Review: Hematologic, Infectious Disease, and Musculoskeletal Systems - A Clinical Reference and Board Review for the PANCE and PANRE (PA ... Recertification Review Book 4 Volume Series) by PA Blueprint Review
1/3

Book Condition: Used — Like New

PA Blueprint Review: Hematologic, Infectious Disease, and Musculoskeletal Systems - A Clinical Reference and Board Review for the PANCE and PANRE (PA ... Recertification Review Book 4 Volume Series) by PA Blueprint Review

$32.99
Sale price  $32.99 Regular price 
ISBN: 9798185293669

Volume 3 of PA Blueprint Review covers the hematologic, infectious diseases, and musculoskeletal systems in 124 standardized condition entries—built for physician assistant students preparing for the PANCE, certified PAs recertifying for the PANRE, and clinicians who need a single authoritative reference. What Is Inside The hematologic section covers the anemias by mechanism—microcytic, macrocytic, normocytic, and hemolytic—and the workup that distinguishes them; the leukemias and lymphomas; multiple myeloma and the plasma cell disorders; the inherited and acquired bleeding disorders; the thrombophilias and coagulation cascade pathology; sickle cell disease and the thalassemias; and transfusion medicine fundamentals. The infectious diseases section is the volume's clinical workhorse. It covers community- and hospital-acquired pneumonia; tuberculosis; HIV and the opportunistic infections aligned to current IDSA guidance; sepsis and the bacteremias; meningitis and encephalitis; the sexually transmitted infections; viral hepatitis A through E; the parasitic infections seen in U.S. and global practice; the tick-borne and zoonotic illnesses; and current SARS-CoV-2 and influenza coverage—each with empiric antibiotic and antiviral guidance grounded in the most recent society standards. Read more

You may also like